CCR6 and COVID-19: In the peripheral blood of patients recovered from COVID-19, the proportion of CXCR3+CCR6– Tfh1 and CXCR3–CCR6– Tfh2 cells increased compared to the control, while the CXCR3–CCR6+ Tfh17 cell count was significantly reduced [121] (Figure 4).